Biotech Fund Dumps Million: What It Signals for Investors
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Understand when rebalancing triggers capital gains taxes and how to plan for them. This intro highlights key rules and proactive strategies.
23,600 articlesA major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Prediction-market odds now place bitcoin's year-end odds reaching 10%. This article breaks down what that means for y...
Cathie Wood goes selling has people watching Ark Invest closely. This article breaks down three key trims, the reason...
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
A single insider trade can spark headlines, but it isn’t a crystal ball. This guide explains how to read a director s...
Big banks are signaling a shift in U.S. stocks. This article breaks down three core reasons behind the downgrade and ...
As wage growth stalls for some workers, investors pursue dividend income. This piece examines how a $500,000 dividend...
As rates stay elevated and markets shift, retirees are rethinking how to fund living costs without eroding the inheri...
Choosing crypto exposure can feel overwhelming. This guide compares FBTC and ETHA, unpacking costs, risk, and real‑wo...
Kick off the holiday with a focused investing reading list. This Friday Juneteenth reads roundup blends market insigh...
Real estate ETFs give you exposure to property markets without being a landlord. This guide compares REET and VNQ, fo...
Choosing a global ETF means balancing cost, diversification, and performance. This guide compares Vanguard VT and Sta...